Phage Displayed HBV Core Antigen with Immunogenic Activity

被引：17

作者：

Bahadir, Aylin Ozdemir ^{[1
]}

Balcioglu, Bertan Koray ^{[1
]}

Uzyol, Kamil Serkan ^{[1
]}

Hatipoglu, Ibrahim ^{[1
]}

Sogut, Ibrahim ^{[1
]}

Basalp, Aynur ^{[1
]}

Erdag, Berrin ^{[1
]}

机构：

[1] Genet Engn & Biotechnol Inst, Tubitak Marmara Res Ctr, TR-41470 Gebze, Kocaeli, Turkey

来源：

APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY | 2011年 / 165卷 / 7-8期

关键词：

HBcAg; Phage display; M13; phage; Immune response; ELISA; Monoclonal antibody; RANDOM-PEPTIDE LIBRARIES; HEPATITIS-B SURFACE; MONOCLONAL-ANTIBODIES; FILAMENTOUS PHAGE; IMMUNOLOGICAL-PROPERTIES; ESCHERICHIA-COLI; VIRUS INFECTION; IMMUNIZATION; EPITOPE; REGION;

D O I：

10.1007/s12010-011-9365-1

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Hepatitis B is a major public health problem worldwide, which may lead to chronic liver diseases such as cirrhosis and hepatocellular carcinoma. The hepatitis B core antigen (HBcAg) is one of the major viral proteins, which forms the inner core of hepatitis B virus (HBV) particles. In this study, filamentous bacteriophage M13 was genetically modified to display the polypeptides of HBcAg in order to develop an alternative carrier system. HBcAg gene was inserted into the minor coat protein (pIII) gene of M13, and HBcAg was expressed on the phage surface as a whole protein. Antigenicity and immunogenicity of HBcAg were tested by immunizing BALB/c mice three times with HBcAg-displaying recombinant phages. After successful immunization, one of the mice with high antibody titer to HBcAg was selected for fusion, and four monoclonal antibodies specific for HBcAg were developed. This result showed that HBcAg-displaying recombinant bacteriophages are immunogenic and can potentially be used for the development of monoclonal antibodies.

引用

页码：1437 / 1447

页数：11

共 36 条

[1]

[Anonymous], 1989, Molecular Cloning: A Laboratory

[2]

DELACRUZ VF, 1988, J BIOL CHEM, V263, P4318

[3] Novel short peptides isolated from phage display library inhibit vascular endothelial growth factor activity [J].

Erdag, Berrin ;

Balcioglu, Koray B. ;

Kumbasar, Asli ;

Celikbicak, Omur ;

Zeder-Lutz, Gabrielle ;

Altschuh, Daniele ;

Salih, Bekir ;

Baysal, Kemal .

MOLECULAR BIOTECHNOLOGY, 2007, 35 (01) :51-63

[4] Tumor-Specific Bacteriophages Induce Tumor Destruction through Activation of Tumor-Associated Macrophages [J].

Eriksson, Fredrik ;

Tsagozis, Panagiotis ;

Lundberg, Kajsa ;

Parsa, Roham ;

Mangsbo, Sara M. ;

Persson, Mats A. A. ;

Harris, Robert A. ;

Pisa, Pavel .

JOURNAL OF IMMUNOLOGY, 2009, 182 (05) :3105-3111

[5] The potential of phage display virions expressing malignant tumor specific antigen MAGE-A1 epitope in murine model [J].

Fang, JB ;

Wang, GY ;

Yang, Q ;

Song, JN ;

Wang, Y ;

Wang, L .

VACCINE, 2005, 23 (40) :4860-4866

[6] Immunization against Alzheimer's β-amyloid plaques via EFRH phage administration [J].

Frenkel, D ;

Katz, O ;

Solomon, B .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (21) :11455-11459

[7]

Galfre G, 1981, Methods Enzymol, V73, P3

[8] Immunisation with phage displaying peptides representing single epitopes of the glycoprotein G can give rise to partial protective immunity to HSV-2 [J].

Grabowska, AM ;

Jennings, R ;

Laing, P ;

Darsley, M ;

Jameson, CL ;

Swift, L ;

Irving, WL .

VIROLOGY, 2000, 269 (01) :47-53

[9]

HLOZANEK I, 1987, FOLIA BIOL-PRAGUE, V33, P295

[10] Random-peptide libraries and antigen-fragment libraries for epitope mapping and the development of vaccines and diagnostics [J].

Irving, MB ;

Pan, O ;

Scott, JK .

CURRENT OPINION IN CHEMICAL BIOLOGY, 2001, 5 (03) :314-324

← 1 2 3 4 →